Resmed Inc. buy UBS Group AG
Start price
22.05.23
/
50%
€210.60
Target price
22.05.24
-
Performance (%)
-3.38%
Price
20.05.24
€201.70
This prediction will end soon
Summary
This prediction is currently active. With a performance of -3.38%, the BUY prediction for Resmed Inc. by UBS_Group_AG is down slightly. Dividends of €1.78 are taken into consideration when calculating the performance. This prediction currently runs until 22.05.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.198% | -0.198% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat